PATIENT SUPPORT

Your patients will be matched with a Patient Navigator as their single point of contact.

Our team will work with your patients to help set expectations about what happens next, including disease education, treatment support, and potential solutions for overcoming obstacles to access and affordability. Here's how we can help:

• Education & Expectations: keeping patients informed about their treatment and what’s next in their United Therapeutics treatment journey
• Coverage & Reimbursement: initiating the benefits investigation process and setting expectations on prior authorizations, appeals, and reimbursement needs
• Cost & Savings: education on United Therapeutics co-pay assistance and patient assistance programs for eligible patients
• Prescription Coordination: oversight throughout the referral process, working directly with one of our Specialty Pharmacy partners to triage your prescription, confirm coverage, and monitor prescription status
• Treatment Support: regular patient check-ins and access to Patient Education Specialists who can be an additional resource during your patient’s United Therapeutics treatment journey

United Therapeutics Cares Co-Pay Assistance Program*

With the United Therapeutics Cares Co-Pay Assistance Program, most eligible patients pay as little as a $0 co-pay for each prescription of TYVASO or TYVASO DPI.

For full program details and Terms and Conditions, visit UnitedTherapeuticsCaresCopay.com.

*To enroll in this Program, your patients must understand and agree to comply with the eligibility requirements and terms of use.

Eligibility requirements for this Program are:

• Patients must be 18 years or older to use this Program.
• Patients using Medicare, Medicaid, or any other state or federal government program to pay for their medications are not eligible. Patients who start utilizing government coverage during the term of the Program will no longer be eligible.
• The Program is valid only for patients with commercial (also known as private) insurance who are taking the medication for an FDA-approved indication. The Program is only valid for the cost of the treprostinil product and not applicable to any related supplies or other medical expenses associated with administering the product.
• Eligible patients must be residents of the US or Puerto Rico. The Program is subject to additional state law restrictions. Patients residing in select states may not be eligible for the Program.